ACCESSION: MSBNK-SMB_Measured-HSA001P0259011
RECORD_TITLE: Characterized; Carnosine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 20
COMMENT: RAW_SPEC {'ProcedureBlank_565': {'bp': 112236.0, 'sum': 322399.0}, '3_posi_242': {'bp': 95836.0, 'sum': 273920.0}, '3_posi_38': {'bp': 95738.0, 'sum': 259484.0}, '15_posi_52': {'bp': 86851.0, 'sum': 296198.0}, '6_posi_75': {'bp': 84379.0, 'sum': 243297.0}, '7_posi_411': {'bp': 81930.0, 'sum': 223954.0}, '15_posi_181': {'bp': 79235.0, 'sum': 257551.0}, '8_posi_224': {'bp': 78264.0, 'sum': 217156.0}, '14_posi_222': {'bp': 77157.0, 'sum': 278068.0}, '11_posi_186': {'bp': 76342.0, 'sum': 246502.0}, '11_posi_271': {'bp': 76340.0, 'sum': 195601.0}, '13_posi_326': {'bp': 73229.0, 'sum': 249616.0}, '14_posi_621': {'bp': 72207.0, 'sum': 204293.0}, '1_posi_623': {'bp': 71533.0, 'sum': 181964.0}, '10_posi_621': {'bp': 63584.0, 'sum': 221879.0}, '13_posi_412': {'bp': 62987.0, 'sum': 250889.0}, '5_posi_625': {'bp': 56863.0, 'sum': 191017.0}, '4_posi_666': {'bp': 52786.0, 'sum': 173889.0}, '12_posi_646': {'bp': 50327.0, 'sum': 205366.0}, '16_posi_665': {'bp': 42863.0, 'sum': 164075.0}}
COMMENT: RETENTION_TIME_STDEV 0.455
COMMENT: PRECURSOR_M/Z_RAW 259.139578
COMMENT: PRECURSOR_M/Z_STDEV 0.000168
COMMENT: PRECURSOR_IN_MS1 mz 259.140108; int 10.198; delta(ppm) 1.389210
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+H; mz 227.113832; int 10.984; cor 0.797
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+ACN+H; mz 268.140328; int 7.619; cor 0.750
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+2ACN+H; mz 309.166899; int 4.082; cor 0.837
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.101; C10H18N4O4; [M+H]+; delta(ppm) 0.100723
COMMENT: PROPOSED_MF SevenGoldenRules 0.124; C9H14N4O3; [M+CH3OH+H]+; delta(ppm) 0.123835
COMMENT: PROPOSED_MF MS-FINDER 3.800; C9H14N4O3; [M+CH3OH+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF MS-FINDER 3.765; C10H18N4O4; [M+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS5_Sirius 7.275; C10H18N4O4; [M+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS5_Sirius 7.275; C9H14N4O3; [M+CH4O+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.209; C13H17F3N2; [M+H]+; delta(ppm) -5.988960
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H18N4O4; [M+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H14N4O3; [M+CH4O+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.188; C8H18O7; [M+CH4O+H]+; delta(ppm) 5.259307
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.497; C10H18N4O4; [M+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.497; C9H14N4O3; [M+CH4O+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.448; C7H19FN4O5; [M+H]+; delta(ppm) -4.311076
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.448; C6H15FN4O4; [M+CH4O+H]+; delta(ppm) -4.311076
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.102; C6H17ClN5O2; [M+CH4O+H]+; delta(ppm) -84765.182500
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.504; C6H21N5O4P; [M+H]+; delta(ppm) -1.094491
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.504; C5H17N5O3P; [M+CH4O+H]+; delta(ppm) -1.094491
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.627; C8H16N7O3; [M+H]+; delta(ppm) 5.279565
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.627; C7H12N7O2; [M+CH4O+H]+; delta(ppm) 5.279565
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.565; C12H20NO5; [M+H]+; delta(ppm) -5.082890
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.565; C11H16NO4; [M+CH4O+H]+; delta(ppm) -5.082890
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.234; C4H19N8O3P; [M+H]+; delta(ppm) 4.086751
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.234; C3H15N8O2P; [M+CH4O+H]+; delta(ppm) 4.086751
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.290; C3H18N10O2S; [M+H]+; delta(ppm) -2.548129
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.290; C2H14N10OS; [M+CH4O+H]+; delta(ppm) -2.548129
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.106; C11H14N8; [M+H]+; delta(ppm) -5.062632
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.197; C7H20N3O7; [M+H]+; delta(ppm) 10.440615
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.197; C6H16N3O6; [M+CH4O+H]+; delta(ppm) 10.440615
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.453; C8H17F3N4O2; [M+H]+; delta(ppm) 9.534517
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H18N4O4; [M+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.929; C9H14N4O3; [M+CH4O+H]+; delta(ppm) 0.098311
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.070; C8H18O7; [M+CH4O+H]+; delta(ppm) 5.259307
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C6H15FN4O4; [M+CH4O+H]+; delta(ppm) -4.311076
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C7H12N7O2; [M+CH4O+H]+; delta(ppm) 5.279565
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.327; CXRAZENRYGPIMC-RNFRBKRXSA-N; [M+H]+; C1[C@H](N=C(N1C(=O)N)N)C[C@@H](CCCC(=O)O)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.342; CQOVPNPJLQNMDC-ZETCQYMHSA-N; [M+CH3OH+H]+; Carnosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.806; XZWXFWBHYRFLEF-UHFFFAOYNA-N; [M+CH3OH+H]+; Alanyl-Histidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.765; FRJIAZKQGSCKPQ-UHFFFAOYNA-N; [M+CH3OH+H]+; Histidinyl-Alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.737; XHZMOKNFPZDZBZ-CNGBTNQNSA-N; [M+CH3OH+H]+; (6R)-6-(L-Erythro-1,2-Dihydroxypropyl)-5,6,7,8-tetrahydro-4a-hydroxypterin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.708; CXRAZENRYGPIMC-RNFRBKRXSA-N; [M+H]+; Guadinomic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.551; RRDJEBTUFIAJLJ-GDVGLLTNSA-N; [M+CH3OH+H]+; (2S)-2,5-diamino-5-(4-methyl-5-oxoimidazol-2-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.536; QASRNVMVWIIWKE-UHFFFAOYSA-N; [M+CH3OH+H]+; UNPD112979
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.266; MDJFHRLTPRPZLY-UHFFFAOYSA-N; [M+CH3OH+H]+; nimorazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CXRAZENRYGPIMC-RNFRBKRXSA-N; [M+H]+; Guadinomic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CQOVPNPJLQNMDC-ZETCQYMHSA-N; [M+CH3OH+H]+; Carnosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; XZWXFWBHYRFLEF-UHFFFAOYNA-N; [M+CH3OH+H]+; Alanyl-Histidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.958; XHZMOKNFPZDZBZ-CNGBTNQNSA-N; [M+CH3OH+H]+; (6R)-6-(L-Erythro-1,2-Dihydroxypropyl)-5,6,7,8-tetrahydro-4a-hydroxypterin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.918; RRDJEBTUFIAJLJ-GDVGLLTNSA-N; [M+CH3OH+H]+; (2S)-2,5-diamino-5-(4-methyl-5-oxoimidazol-2-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.915; FRJIAZKQGSCKPQ-UHFFFAOYNA-N; [M+CH3OH+H]+; Histidinyl-Alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.174; QASRNVMVWIIWKE-UHFFFAOYSA-N; [M+CH3OH+H]+; UNPD112979
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.126; MDJFHRLTPRPZLY-UHFFFAOYSA-N; [M+CH3OH+H]+; nimorazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.383; CQOVPNPJLQNMDC-ZETCQYMHSA-N; [M+CH3OH+H]+; (2S)-2-(3-aminopropanoylamino)-3-(1H-imidazol-5-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; HQUUVVMNROIQPJ-UHFFFAOYSA-N; [M+H]+; 1-N',6-N'-diacetylhexanedihydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.502; XZWXFWBHYRFLEF-FSPLSTOPSA-N; [M+CH3OH+H]+; (2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.871; FRJIAZKQGSCKPQ-FSPLSTOPSA-N; [M+CH3OH+H]+; (2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.296; MWNXXTJQAIRBCQ-UHFFFAOYSA-N; [M+H]+; bis(3-amino-3-iminopropyl) butanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; FYLHKMGQCHPNSA-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(1,3-dimethyl-2,6-dioxopyrimidin-4-yl)-3-ethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; XHZMOKNFPZDZBZ-CNGBTNQNSA-N; [M+CH3OH+H]+; (6S)-6-[(2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.072; MRYMQZBPHUXBOH-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(2-hydroxyethoxymethyl)-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; KZISLBUJFANQNO-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(2-morpholin-4-ylethyl)triazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.021; MDJFHRLTPRPZLY-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.259; FEDGCLDYLJUCNC-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.256; VUJXSNIKPYGZMK-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 1-(morpholin-2-ylmethyl)triazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; NAEIQHMISIYBGX-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-[2-(2-nitroimidazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.230; GFAGXHPEIBQWEX-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-4-(2-nitroimidazol-1-yl)butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.230; DUKQUQCVLXBEPC-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(5-ethyl-2-nitroimidazol-1-yl)-N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; PXWGPZUKJUEITG-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-amino-3-methyl-1-(2-methylpropyl)-5-nitrosopyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -116.346; CQOVPNPJLQNMDC; [M+CH4O+H]+; Ignotine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.265; XZWXFWBHYRFLEF; [M+CH4O+H]+; AH zwitterion
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.959; FRJIAZKQGSCKPQ; [M+CH4O+H]+; Histidylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.384; BRGBQBPYMOHKSZ; [M+H]+; N(6)-(2-Imidazolidinone-N-carbonyl)-L-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.637; GFAGXHPEIBQWEX; [M+CH4O+H]+; N,N-Dimethyl-2-nitro-1-imidazolebutyramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.691; MDJFHRLTPRPZLY; [M+CH4O+H]+; Acterol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.695; FYLHKMGQCHPNSA; [M+CH4O+H]+; Uracil, 1,3-dimethyl-5-(ethylurea)-, hydrate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.780; PXWGPZUKJUEITG; [M+CH4O+H]+; 6-Amino-1-isobutyl-3-methyl-5-nitrosouracil
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.567; DUKQUQCVLXBEPC; [M+CH4O+H]+; N,N-Dimethyl-5-ethyl-2-nitroimidazole-1-acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.414; QASRNVMVWIIWKE; [M+CH4O+H]+; hymeniacidin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.866; CXRAZENRYGPIMC; [M+H]+; (5R)-6-[(4R)-2-amino-1-carbamoyl-4,5-dihydroimidazol-4-yl]-5-hydroxyhexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.761; FDSWXSIYVKPLBE; [M+H]+; 6-N,6-N''-diacetylhexanedihydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -322.486; LDQAHTVPOZCQNH; [M+CH4O+H]+; 3''-Amino-2'',3''-dideoxycytidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -337.537; MRYMQZBPHUXBOH; [M+CH4O+H]+; 3-(2-hydroxyethoxymethyl)-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.065; XHZMOKNFPZDZBZ; [M+CH4O+H]+; hydroxypterin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.871; AFLZZBWHQVDQKY; [M+CH4O+H]+; ACMC-20cwat
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.624; CQOVPNPJLQNMDC; [M+CH4O+H]+; Ignotine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.147; BRGBQBPYMOHKSZ; [M+H]+; N(6)-(2-Imidazolidinone-N-carbonyl)-L-lysine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.758; CQOVPNPJLQNMDC; [M+CH4O+H]+; Carnosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -179.548; VFTRCRGWZRMEBJ; [M+H]+; (2S)-2-[(2-aminoacetyl)amino]-N-[(2S)-1-oxo-1-(2-oxoethylamino)propan-2-yl]propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.835; XZWXFWBHYRFLEF; [M+CH4O+H]+; (2S)-2-{[(2S)-2-azaniumylpropanoyl]amino}-3-(1H-imidazol-5-yl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -193.720; FRJIAZKQGSCKPQ; [M+CH4O+H]+; 2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -238.699; FYLHKMGQCHPNSA; [M+CH4O+H]+; Urea, 1-ethyl-3-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)-, hydrate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.708; MRYMQZBPHUXBOH; [M+CH4O+H]+; 3,6,7,8-Tetrahydro-3-((2-hydroxyethoxy)methyl)imidazo(4,5-d)(1,3)diazepin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -269.626; RRDJEBTUFIAJLJ; [M+CH4O+H]+; delta-(5-Methyl-4-imidazolon-2-yl)ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -272.670; PXWGPZUKJUEITG; [M+CH4O+H]+; [4-Amino-1-methyl-3-(2-methylpropyl)-2,6-dioxopyrimidin-5-yl]-oxoazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -283.797; DUKQUQCVLXBEPC; [M+CH4O+H]+; N,N-Dimethyl-5-ethyl-2-nitroimidazole-1-acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -286.300; FDSWXSIYVKPLBE; [M+H]+; 6-N,6-N'-diacetylhexanedihydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -291.309; QASRNVMVWIIWKE; [M+CH4O+H]+; N-[1,3-dimethyl-6-(methylamino)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl]-N-methylformamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.433; GFAGXHPEIBQWEX; [M+CH4O+H]+; N,N-Dimethyl-2-nitro-1-imidazolebutyramide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -317.041; BRGBQBPYMOHKSZ; [M+H]+; (2S)-2-amino-6-[(2-oxoimidazolidine-1-carbonyl)amino]hexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -497.180; CXRAZENRYGPIMC; [M+H]+; Guadinomic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.649; CQOVPNPJLQNMDC; [M+CH4O+H]+; Carnosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.159; VFTRCRGWZRMEBJ; [M+H]+; (2S)-2-[(2-aminoacetyl)amino]-N-[(2S)-1-oxo-1-(2-oxoethylamino)propan-2-yl]propanamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, Carnosine, CQOVPNPJLQNMDC-ZETCQYMHSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000033;
CH$NAME: Carnosine
CH$NAME: (2S)-2-(3-aminopropanoylamino)-3-(1H-imidazol-5-yl)propanoic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H14N4O3
CH$EXACT_MASS: 226.106590
CH$SMILES: C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CCN
CH$IUPAC: InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1
CH$LINK: CHEBI CHEBI:15727
CH$LINK: HMDB HMDB0000033
CH$LINK: INCHIKEY CQOVPNPJLQNMDC-ZETCQYMHSA-N
CH$LINK: PUBCHEM CID:439224
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 0.775
MS$FOCUSED_ION: ION_TYPE [M+CH3OH+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 259.140107
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-0190000000-9f6ee701cbe25f85c00b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  143.0816397 167.9685 143.081542 2.2644 50.69 0.3985 20 f{C6H11N2O2}/0.95ppm,p-C4H8N2O2
  171.0766441 105.7471 171.076528 2.5427 29.85 0.5316 19 f{C7H11N2O3}/1.32ppm,p-C3H8N2O1
  213.1350200 196.6373 213.134878 1.8204 61.62 0.4496 20 f{C9H17N4O2}/1.96ppm,p-C1H2O2
  231.1453342 143.1550 231.145181 2.4530 51.98 0.2570 18 f{C9H19N4O3}/0.72ppm,p-C1O1
  241.1295426 377.1824 241.129383 1.2981 91.32 0.7895 20 f{C10H17N4O3}/0.11ppm,p-H2O1
  241.1657496 140.5873 241.165591 2.4340 42.86 -0.0496 20 ?
  259.1388989 430.8583 259.138729 2.2035 85.44 1.0000 20 f{C10H19N4O4}/-4.56ppm,p
  259.1678644 999.0000 259.167694 2.8283 0.00 0.6602 20 ?
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  143.081640 167.97 167
  171.076644 105.75 105
  213.135020 196.64 196
  231.145334 143.16 143
  241.129543 377.18 377
  241.165750 140.59 140
  259.138899 430.86 430
  259.167864 999.00 999
//
